Good Health Can’t Wait.

More documents

Recommendations

Info

Good Health Can’t Wait. Dr. Reddy’s Laboratories Limited 19,800+ Employees worldwide. (i) Preventable, (ii) Strategic and (iii) External risks. The Finance, Investment and Risk Management Council (or FIRM Council), is the Company’s management committee that helps the ERM function to prioritize organization-wide risks, review and steer mitigation efforts in line with the Company’s risk capacity and appetite. The FIRM council also oversees financial risk management and capital allocation decisions. REVIEWING THE STATUS OF MITIGATION AND RESIDUAL RISKS The Head of Dr. Reddy’s ERM team provides periodic updates to the FIRM Council and the Risk Committee of the Board of Directors. These include: (i) quarterly updates on the progress of mitigation of key risks, and (ii) specific initiatives carried out on risks during the year. During FY2015, the ERM team facilitated mitigation for certain geo-political and country risks, on forex and devaluation of currencies, on transfer risk and on people security. The team enhanced its key risk indicator tracking capabilities, developed a loss-data tracker and constructed a key learning’s summary for the year. On financial risk management, the team helped in developing a framework to enable making capital allocation decisions. It also assisted management in documentation and review of internal financial controls as required by the Companies Act, 2013. HUMAN RESOURCES Adjudged among the best employers in India, we at Dr. Reddy’s periodically renew our HR strategy to better engage with people and drive productivity across our 19,800-plus employees worldwide. Currently, our HR Strategy is designed to place our People Managers at the heart of all our employee practices. In this, we have stepped up our investments in leadership development and talent management programs. Our focus on leadership development and talent management was further strengthened this year. We continue to invest in our leadership development program which is built on the four tenets of ‘Lead Self, Lead Others, Lead Change and Lead Business’. The participants are beginning to show significant shifts in their development journey and the organization is benefiting through unique breakthrough projects that have been undertaken. We received CNBC ASIA’s India Talent Management Award this year as a recognition for our effective talent management practices. Dr. Reddy’s is an employer of choice for women. We lay special emphasis on helping our women colleagues grow professionally and personally as a part of our strategy to attract and retain the best talent in the industry. This year we made distinct progress in this area and rolled out our enabling policies and programs to help enhance gender diversity. Our focus on productivity also got an impetus as we benchmarked our productivity with industry and executed organizational design interventions that focused on delayering, reducing spans, sharply defining roles and agreeing on tighter manning norms. We also launched our new HR IT portal to help automate key HR processes. OUTLOOK The Company believes that its focus on profitable growth and targeting a leadership position in Global Generics and PSAI will create significant value in the near term. In GG, improving depth through portfolio expansion, cost leadership, consistent delivery of limited competition products and supply chain excellence should lead us to leadership positions in key markets. In PSAI, the objective is to be the partner of choice by creating compelling value 52
Statutory Reports • Management Discussion and Analysis Annual Report 2014 - 15 We received CNBC ASIA’s India Talent Management Award this year as a recognition for our effective talent management practices. information that is included in this report. This write-up includes some forward-looking statements, as defined in the US Private Securities Litigation Reform Act of 1995. The management has based these forward-looking statements on its current expectations and projections about future events. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. These factors include, but are not limited to, changes in local and global economic conditions, the Company’s ability to successfully implement its strategy, the market’s acceptance of and demand for its products, growth and expansion, technological change and exposure to market risks. By their nature, these expectations and projections are only estimates and could be materially different from actual results in the future. for customers through leveraging IP, technology and cost leadership. In Proprietary Products, the aim is to create a viable business by calibrating investments to produce a selfsustainable model. The Company has a positive outlook for the next year. The largest increment of growth is expected to be contributed by the North America generics and Emerging Markets businesses. In a dynamic environment, Dr. Reddy’s base business model is exposed to volatility, both upwards and downwards. While the upsides create non-linear value for the organization, there is a conscious attempt to protect it against the downsides. CAUTIONARY STATEMENT The management of Dr. Reddy’s has prepared and is responsible for the financial statements that appear in this report. These financial statements are in conformity with International Financial Reporting Standards, as issued by the International Accounting Standards Board and accounting principles generally accepted in India and therefore include amounts based on informed judgments and estimates. The management also accepts responsibility for the preparation of other financial The Company has a positive outlook for the next year. The largest increment of growth is expected to be contributed by the North America generics and Emerging Markets businesses. 53
Page 1 and 2:
ANNUAL REPORT 2014-15 Good Health C
Page 3 and 4: Our Brand We are in the business of
Page 5 and 6: Corporate Overview Annual Report 20
Page 29 and 30: Statutory Reports • Business Resp
Page 43 and 44: Statutory Reports • Management Di
Page 53: Statutory Reports • Management Di
Page 57 and 58: Statutory Reports • Corporate Gov
Page 73 and 74: Statutory Reports • Additional Sh
Page 87 and 88: Statutory Reports • Board’s Rep
Page 105 and 106:
Statutory Reports • Board’s Rep
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Standalone Financial Statements Ann
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Consolidated Financial Statements A
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Notice Annual Report 2014 - 15 NOTI
Page 229 and 230:
E-Voting Annual Report 2014 - 15 IN
Page 231:
Dr. Reddy’s Laboratories Limited
Page 235 and 236:
The future belongs, not to those wh
show all

Good Health Can’t Wait.

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?